Xin Lang Cai Jing·2025-09-30 07:56Core Points - Zhejiang Huayuan Biopharmaceutical Co., Ltd. announced that the employee stock ownership plan established in 2022 has been fully liquidated [1] - As of September 30, 2022, 7,674,790 shares were transferred to the employee stock ownership plan's securities account, with a duration of 42 months and a two-batch unlocking mechanism, each unlocking 50% [1] - The first and second unlocking dates are set for September 28, 2023, and September 28, 2024, respectively [1] - As of the announcement date, all 7,674,790 shares, representing 1.41% of the company's total share capital, have been sold through centralized bidding [1] - The company will proceed with asset liquidation and distribution, and will terminate the plan as per regulations [1]